Petrovax is a leading Russian company engaged in research, development and production of innovative pharmaceuticals.
Business Model:
Revenue: $0
Employees: 501-1,000
Address:
City: Naberezhnaya
State: Permskiy Kray
Zip:
Country: Russian Federation
Petrovax is a leading Russian company engaged in research, development and production of innovative pharmaceuticals. The company owns a portfolio of original products, including vaccines, immune system medicines and prolonged biotech drugs. The company operates a modern GMP-compliant facility in the Moscow Region with annual capacity in liquid forms well above 150mn doses. Petrovax was one of the first Russian companies to receive a European GMP certificate and remains one of the few exporters of locally developed and produced drugs into the EU and the Middle East. Today Petrovax is the largest vaccines exporter in Russia. In 2020 Petrovax deeply engaged in COVID-19 Vaccine and Medication research and development, becoming the first Russian company to receive phase 3 clinical trial approvals for both.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2014 | Venture Round | 1 | - |
Winter Capital Winter Capital |
2/2014 | Venture Round | 1 | - |
Winter Capital Winter Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|